期刊文献+

保乳手术治疗三阴乳腺癌的安全性及其预后分析 被引量:4

Safety and prognostic analysis on breast-conserving surgery in treating triple negative breast cancer
下载PDF
导出
摘要 目的探讨保乳手术治疗三阴乳腺癌的安全性及接受保乳治疗的三阴乳腺癌的临床预后特点。方法 718例接受保乳手术治疗病例,其中三阴乳腺癌111例,非三阴乳腺癌607例,比较两组的局部复发率和远处转移率。结果中位随访50.5个月,三阴乳腺癌和非三阴乳腺癌的局部复发分别为3例(2.7%)和14例(2.3%),两者间无复发生存率无统计学差异(97.3%vs97.7%,P=0.883);远处转移分别为4例(3.6%)和21例(3.5%),无远处转移生存率没有统计学差异(96.4%vs96.5%,P=0.726)。结论保乳手术治疗三阴乳腺癌安全,有效,其局部复发率与远处转移率与非三阴乳腺癌患者相当。 Objective To evaluate the security of breast conserving surgery (BCS) in triple negative breast cancer (TNBC) and prognostic features of TNBC underwent BCS compared to non- triple negative breast cancer (non-TNBC). Methods Of 718 patients underwent BCS, 111 were TNBC, and 607 were non-TNBC. Loeal-regiongal recurrence and distant metastasis were analyzed inthese two subgroups. Results With a median follow-up period of 50.5 months,3 (2.7%)cases in TNBC and 14 (2.3%) cases in non-TNBC appeared local-regiongal recurrence,4 (3.6%) patients in TNBC and 21 (3.5%) patients in non-TNBC developed distant metastasis. The Local-regional Recurrence free survival and disease metastasis free survival between two groups were Comparable. Conclusions Breast conservation is a safty and effective treatment for TNBC.
出处 《岭南现代临床外科》 2012年第5期241-244,265,共5页 Lingnan Modern Clinics in Surgery
基金 国家自然科学基金 编号:81172524 国家自然科学基金 编号:30972785
关键词 三阴乳腺癌 保乳手术 局部复发 远处转移 Triple negative breast cancer Breast conserving surgery Local-regional Recurrence, Distant Metastasis
  • 相关文献

参考文献21

  • 1Perou CM,Sorlie T,Eisen MB. Molecular portraits of human breast tumours[J].Nature,2000,(6797):747-752. 被引量:1
  • 2Sorlie T,Perou CM,Tibshirani R. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proceedings of the National Academy of Sciences(USA),2001,(19):10869-10874. 被引量:1
  • 3Carey LA,Perou CM,Livasy CA. Race,breast cancer subtypes,and survival in the Carolina Breast Cancer Study[J].Journal of the American Medical Association,2006,(26):2492-2502. 被引量:1
  • 4Cleator S,Heller W,Coombes RC. Triple-negative breast cancer:therapeutic options[J].Lancet Oncology,2007,(03):235-244. 被引量:1
  • 5Rakha EA,El-Rehim DA,Paish C. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance[J].European Journal of Cancer,2006,(18):3149-3156. 被引量:1
  • 6Nielsen TO,Hsu FD,Jensen K. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J].Clinical Cancer Research,2004,(16):5367-5374.doi:10.1158/1078-0432.CCR-04-0220. 被引量:1
  • 7Sorlie T,Tibshirani R,Parker J. Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proceedings of the National Academy of Sciences(USA),2003,(14):8418-8423.doi:10.1073/pnas.0932692100. 被引量:1
  • 8Rakha EA,El-Sayed ME,Green AR. Prognostic markers in triple-negative breast cancer[J].Cancer,2007,(01):25-32.doi:10.1002/cncr.22381. 被引量:1
  • 9Siziopikou KP,Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies[J].Breast,2007,(01):104-107. 被引量:1
  • 10Livasy CA,Karaca G,Nanda R. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma[J].Modern Pathology,2006,(02):264-271.doi:10.1038/modpathol.3800528. 被引量:1

同被引文献12

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部